Product Details
Product Name:
Bococizumab |
CAS No.:
1407495-02-6 |
Purity:
97.7% (SEC-HPLC) |
Supply Ability:
10g |
Release date:
2024/11/15 |
Product Introduction
Bioactivity
名稱(chēng) | Bococizumab |
描述 | Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia. |
體內(nèi)活性 | Bococizumab (0, 10, 30, and 100 mg/kg; i.v.; Pregnant Sprague-Dawley (SD) rats) decreases maternal and fetal cholesterol and shows good tolerance and no effects on ovarian or uterine parameters.[2] |
存儲(chǔ)條件 | store at low temperature | store at -20°C | Shipping with blue ice. |
關(guān)鍵字 | RN-316 | RN 316 | PF04950615 | PF 04950615 | Bococizumab |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1962178-27-3
$44.00 / 1mg
-
CAS:2768216-96-0
$106.00 / 1mg
-
CAS:498-02-2
$50.00 / 1mL
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |